$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023038569 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$5.097M	$5.504M	$8.605M
YoY Change	-32.53%	-36.03%	-6.35%
Cost Of Revenue	$5.063M	$5.573M	$6.118M
YoY Change	-25.35%	-8.9%	-29.11%
Gross Profit	$33.63K	-$69.47K	$2.486M
YoY Change	-95.64%	-102.79%	346.7%
Gross Profit Margin	0.66%	-1.26%	28.9%
Selling, General & Admin	$1.460M	$1.876M	$923.4K
YoY Change	64.36%	103.19%	4.88%
% of Gross Profit	4341.54%		37.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$92.47K	$92.19K	$104.8K
YoY Change	-12.89%	-12.05%	14.95%
% of Gross Profit	274.97%		4.22%
Operating Expenses	$5.644M	$3.191M	$2.068M
YoY Change	168.81%	54.32%	20.34%
Operating Profit	-$5.611M	-$3.260M	$418.9K
YoY Change	322.55%	-878.26%	-136.07%
Interest Expense	$524.0K	$287.4K	$48.85K
YoY Change	616.53%	488.29%	13357.02%
% of Operating Profit			11.66%
Other Income/Expense, Net	$55.33K	-$259.4K	$82.84K
YoY Change	-82.17%	-413.11%	384.22%
Pretax Income	-$5.556M	-$3.519M	$501.7K
YoY Change	445.95%	-801.46%	-143.84%
Income Tax
% Of Pretax Income
Net Earnings	-$5.556M	-$3.519M	-$717.2K
YoY Change	292.52%	390.74%	-64.74%
Net Earnings / Revenue	-108.99%	-63.94%	-8.33%
Basic Earnings Per Share	-$0.37	-$0.25	-$0.06
Diluted Earnings Per Share	-$0.37	-$0.25	-$59.77K
COMMON SHARES
Basic Shares Outstanding	14.30M shares	14.31M shares	12.00M shares
Diluted Shares Outstanding	14.89M shares	14.00M shares	12.00M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.601M	$1.453M	$13.15M
YoY Change	-34.05%	-88.95%	24.73%
Cash & Equivalents	$1.601M	$1.453M	$13.15M
Short-Term Investments
Other Short-Term Assets	$2.232M	$1.307M	$7.592M
YoY Change	-46.63%	-82.79%	-66.85%
Inventory	$823.1K	$12.99K	$1.054M
Prepaid Expenses
Receivables	$646.3K	$1.012M	$2.425M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.327M	$9.045M	$21.94M
YoY Change	-38.61%	-58.77%	22.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.990M	$6.044M	$4.081M
YoY Change	45.43%	48.11%	18.15%
Goodwill	$1.309M	$1.309M	$1.309M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$1.996M	$2.033M	$2.053M
YoY Change	-0.82%	-1.0%	-7.53%
Long-Term Investments	$4.325M	$4.325M	$4.300M
YoY Change	0.58%	0.58%
Other Assets	$50.98K	$61.18K	$102.0K
YoY Change	-44.45%	-40.0%	-27.17%
Total Long-Term Assets	$18.54M	$19.40M	$16.03M
YoY Change	9.38%	21.02%	70.43%
TOTAL ASSETS
Total Short-Term Assets	$9.327M	$9.045M	$21.94M
Total Long-Term Assets	$18.54M	$19.40M	$16.03M
Total Assets	$27.86M	$28.44M	$37.96M
YoY Change	-13.3%	-25.08%	39.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.026M	$5.702M	$5.476M
YoY Change	57.45%	4.12%	-9.04%
Accrued Expenses	$307.1K	$415.8K	$461.6K
YoY Change	-33.2%	-9.92%	12.58%
Deferred Revenue	$168.8K	$344.1K	$5.206M
YoY Change	-90.46%	-93.39%	359.33%
Short-Term Debt	$6.815M	$5.396M	$1.985M
YoY Change		171.87%
Long-Term Debt Due	$769.3K	$696.3K	$19.64K
YoY Change	3787.27%	3445.47%	-1.8%
Total Short-Term Liabilities	$15.11M	$12.56M	$13.15M
YoY Change	73.35%	-4.51%	68.36%
LONG-TERM LIABILITIES
Long-Term Debt	$3.034M	$1.555M	$756.7K
YoY Change	303.68%	105.46%	2422.27%
Other Long-Term Liabilities	$397.0K	$2.005M	$2.420M
YoY Change	-82.8%	-17.18%	114.19%
Total Long-Term Liabilities	$3.431M	$3.559M	$3.177M
YoY Change	12.14%	12.03%	173.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.11M	$12.56M	$13.15M
Total Long-Term Liabilities	$3.431M	$3.559M	$3.177M
Total Liabilities	$18.54M	$16.12M	$16.33M
YoY Change	57.44%	-1.29%	82.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$50.50M	-$44.95M	-$33.83M
YoY Change	43.31%	32.88%	39.14%
Common Stock	$160.2K	$143.0K	$120.1K
YoY Change	32.91%	19.12%	36.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$92.40K	$49.68K
YoY Change
Treasury Stock Shares	67.32K shares	23.12K shares
Shareholders Equity	$9.754M	$12.75M	$20.32M
YoY Change
Total Liabilities & Shareholders Equity	$27.86M	$28.44M	$37.96M
YoY Change	-13.3%	-25.08%	39.32%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$5.556M	-$3.519M	-$717.2K
YoY Change	292.52%	390.74%	-64.74%
Depreciation, Depletion And Amortization	$92.47K	$92.19K	$104.8K
YoY Change	-12.89%	-12.05%	14.95%
Cash From Operating Activities	-$1.660M	-$1.379M	$3.257M
YoY Change	-80.74%	-142.33%	-249.19%
INVESTING ACTIVITIES
Capital Expenditures	$30.66K	$531.1K	$922.9K
YoY Change	-106.25%	-42.45%	7.05%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$25.00K	-$599.2K
YoY Change	-100.0%	-95.83%	565.82%
Cash From Investing Activities	-$30.66K	-$638.3K	-$1.861M
YoY Change	-97.48%	-65.7%	87.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.840M	$2.887M	-$1.274M
YoY Change	-308.61%	-326.59%	-281.11%
NET CHANGE
Cash From Operating Activities	-1.660M	-$1.379M	$3.257M
Cash From Investing Activities	-30.66K	-$638.3K	-$1.861M
Cash From Financing Activities	1.840M	$2.887M	-$1.274M
Net Change In Cash	148.8K	$869.7K	$122.0K
YoY Change	-101.39%	612.67%	-104.94%
FREE CASH FLOW
Cash From Operating Activities	-$1.660M	-$1.379M	$3.257M
Capital Expenditures	$30.66K	$531.1K	$922.9K
Free Cash Flow	-$1.691M	-$1.910M	$2.334M
YoY Change	-79.2%	-181.82%	-176.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12750662	usd
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	990 Biscayne Blvd.,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	#501, Office 12
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33132
CY2023Q1	dei	City Area Code CityAreaCode	(646)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	240-4235
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1012172	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	900717	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	36384	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4400361	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4396826	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	12989	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	465560	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1266523	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744211	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9045263	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7506213	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6044259	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2023Q1	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	565809	usd
CY2022Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	483546	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1309330	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1309330	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4190316	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4421002	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	866781	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	857534	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2032894	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1997833	usd
CY2023Q1	us-gaap	Deferred Costs DeferredCosts	61178	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	71374	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3624945	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	usd
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	SGBX
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14302587	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1452501	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38037
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SAFE & GREEN HOLDINGS CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	us-gaap	Assets Assets	28440775	usd
CY2022Q4	us-gaap	Assets Assets	26555680	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5701514	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4009522	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	344129	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1112102	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1225394	usd
CY2023Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2022Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	5396276	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	2648300	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12559816	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8326282	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2809321	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3039836	usd
CY2023Q1	us-gaap	Liabilities Liabilities	16119137	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12116118	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14302587	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14225788	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12613978	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12590863	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	143026	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	126140	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57605024	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56173977	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	23115	shares
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	23115	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	49680	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	49680	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44947708	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41428268	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14822169	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-429024	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-382607	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12321638	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28440775	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26555680	usd
CY2023Q1	us-gaap	Revenues Revenues	5503935	usd
CY2022Q1	us-gaap	Revenues Revenues	8604598	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	5573407	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	6118163	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-69472	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	2486435	usd
CY2023Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1314390	usd
CY2022Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1144187	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1788956	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	780021	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	87251	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	143335	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3190597	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2067543	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3260069	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	418892	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	287372	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	48849	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	9362	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	12783	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18639	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	118902	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-259371	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82836	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3519440	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	501728	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3519440	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	501728	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1218905	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3519440	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-717177	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14003933	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14003933	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11998334	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11998334	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	689086	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1274000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	501728	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21632603	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	656369	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	437325	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	354239	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46417	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3519440	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12321638	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3519440	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	501728	usd
CY2023Q1	us-gaap	Depreciation Depreciation	92193	usd
CY2022Q1	us-gaap	Depreciation Depreciation	104825	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46119	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	41823	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	10196	usd
CY2022Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	10196	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	169040	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8628	usd
CY2023Q1	sgbx	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	230690	usd
CY2022Q1	sgbx	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	109308	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	437325	usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7024	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	9247	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	9247	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	656369	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	649090	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-241	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-268284	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-486117	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	864333	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	91479	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-452571	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-219483	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	522314	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	128592	usd
CY2023Q1	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	81180	usd
CY2022Q1	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent		usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1691992	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2052971	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-93142	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3768133	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-264451	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-343808	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-102829	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1378685	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3257027	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	531083	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	922865	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	760	usd
CY2023Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2022Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	100000	usd
CY2023Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	82265	usd
CY2022Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	338885	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	25000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
CY2023Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	500000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-638348	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1860990	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2500000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	5433175	usd
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	46417	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1274000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2886758	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1274000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	869725	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	122037	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	582776	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1452501	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13146418	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segments
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1306849	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1306849	usd
CY2023Q1	sgbx	Working Capital WorkingCapital	3515000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period, together with amounts disclosed in the related notes to the financial statements. <span style="font-family: 'times new roman', times; line-height: inherit;">The Company's estimates used in these financial statements include, but are not limited to, revenue recognition, stock-based compensation, accounts receivable reserves, inventory valuations, goodwill, the valuation allowance related to the Company’s deferred tax assets, the carrying amount of intangible assets, right of use assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span></span></span></span></p> </div> </div> </div> </div>
CY2023Q1	sgbx	No Of Operating Cycles NoOfOperatingCycles	one year
CY2023Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	0	usd
CY2022Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	6885828	usd
CY2023Q1	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	0	usd
CY2023Q1	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	5503935	usd
CY2022Q1	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	6885828	usd
CY2022Q1	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	1718770	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5503935	usd
CY2023Q1	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8604598	usd
CY2022Q1	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2023Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306143	usd
CY2023Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	usd
CY2023Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	142747	usd
CY2023Q1	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	10196	usd
CY2022Q1	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	10196	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	600000	usd
CY2021Q2	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	350329	usd
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3000000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	25000	usd
CY2023Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1452501	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	97164	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1027082	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	857554	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	46119	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	41823	usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	142605	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	190271	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	186854	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	169519	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	165841	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1177804	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2032894	usd
CY2021Q2	sgbx	Project Development Costs ProjectDevelopmentCosts	824231	usd
CY2021Q2	sgbx	Project Development Costs Book Value ProjectDevelopmentCostsBookValue	4400361	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any </span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">significant </span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">credit risk on the account. <br/></span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At March 31, 2023 and December 31, 2022, 80% and 80%, respectively, of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none; line-height: inherit;">two</span> and three customers. </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Revenue relating to one and two customers represented approximately 95% and 90% of the Company's total revenue for the <span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; line-height: inherit;">three months ended March 31, 2023</span></span><span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; line-height: inherit;"> and </span></span><span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">2022</span></span></span><span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; line-height: inherit;">, respectively.</span></span></span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><br/></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Cost of revenue relating to two <span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: black; line-height: inherit;">vendors represented approximately </span></span><span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000; line-height: inherit;">28% of the Company’s total cost of revenue for the </span></span><span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: black; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">three months ended March 31, 2022.</span></span></span></span><span style="line-height: inherit;"><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000; line-height: inherit;"> For the three months ended <span style="color: #000000; font-family: 'Times New Roman', 'serif'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">March 31</span>, 2023 there were no vendors that represented 10% or more of our cost of revenue. </span></span></span><span style="color: #000000; font-family: 'times new roman', times; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></span></p>
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1157918	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1426202	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	145746	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	145746	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1012172	usd
CY2023Q1	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	7606868	usd
CY2022Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	13730177	usd
CY2023Q1	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2022Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2023Q1	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	657694	usd
CY2022Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-2160085	usd
CY2023Q1	sgbx	Contract Assets Gross ContractAssetsGross	8264562	usd
CY2022Q4	sgbx	Contract Assets Gross ContractAssetsGross	11570092	usd
CY2023Q1	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	7707974	usd
CY2022Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	11970979	usd
CY2023Q1	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	556588	usd
CY2022Q4	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-400887	usd
CY2023Q1	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	900717	usd
CY2022Q4	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	36384	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	344129	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2023Q1	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	556588	usd
CY2022Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-400887	usd
CY2023Q1	sgbx	Total Finance Lease Liabilities TotalFinanceLeaseLiabilities	1501021	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6855178	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6327629	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	810919	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	718726	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6044259	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2023Q1	us-gaap	Depreciation Depreciation	92193	usd
CY2022Q1	us-gaap	Depreciation Depreciation	104825	usd
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2000000	usd
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	usd
CY2023Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4134	usd
CY2022Q3	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	500000	usd
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	usd
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	usd
CY2023Q1	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	2396732	usd
CY2023Q1	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	415772	usd
CY2023Q1	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	2004630	usd
CY2023Q1	sgbx	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	2420402	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1793584	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	696330	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	804691	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	389803	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	608122	usd
CY2023Q1	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	997925	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	523722	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	801869	usd
CY2023Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	1325591	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	446349	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	136234	usd
CY2023Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	582583	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	207379	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	207379	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1119901	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	1119901	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear		usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2687154	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1546225	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	4233379	usd
CY2023Q1	sgbx	Total Operating Imputed Interest TotalOperatingImputedInterest	266753	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	45204	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	311957	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2420401	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	1501021	usd
CY2023Q1	sgbx	Presentvalueofleaseliabilities Presentvalueofleaseliabilities	3921422	usd
CY2023Q1	us-gaap	Share Price SharePrice	0
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
CY2023Q1	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear		usd
CY2022	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	13803733	usd
CY2023Q1	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-22	usd
CY2022	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-1086301	usd
CY2023Q1	sgbx	Construction Backlog Gross ConstructionBacklogGross	6810784	usd
CY2022	sgbx	Construction Backlog Gross ConstructionBacklogGross	18107943	usd
CY2023Q1	sgbx	Contract Revenue ContractRevenue	5503935	usd
CY2022	sgbx	Contract Revenue ContractRevenue	11297181	usd
CY2023Q1	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	1306849	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1306849	usd
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	usd
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	287512	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	437325	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1351097	shares
CY2020Q2	sgbx	Warrants To Purchase WarrantsToPurchase	300000	shares
CY2020Q2	us-gaap	Share Price SharePrice	3.14
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-05-05
CY2021Q4	sgbx	Warrants To Purchase WarrantsToPurchase	1898630	shares
CY2021Q4	us-gaap	Share Price SharePrice	4.8
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2016Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	25000	shares
CY2016Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3625000	shares
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	376060	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1602133	usd
CY2023Q1	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	656369	usd
CY2022Q1	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	649090	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2023Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2023Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P4Y1M2D
CY2023Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2022Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M2D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2023Q1	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M2D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1190935	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	262813	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	928122	shares
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	usd
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	usd
CY2019Q2	sgbx	Unpaid Wages UnpaidWages	30428.71	usd
CY2021Q3	sgbx	Recovery Of Damages Sought RecoveryOfDamagesSought	67125.83	usd
CY2021Q2	us-gaap	Other Commitments Description OtherCommitmentsDescription	provide for an annual base salary of $400,000 provide for a performance bonus structure for a bonus of up to 50% of base salary upon the Company’s achievement of $2,000,000 EBITDA and additional performance bonus payments for the achievement of EBITDA in excess of $2,000,000 based on a percentage of the incremental increase in EBITDA (ranging from 10% of the incremental increase in EBITDA if the Company achieves over $2,000,000 and up to $7,000,000 in EBITDA, 8% of the incremental increase in EBITDA if the Company achieves over $7,000,000 and up to $12,000,000 in EBITDA and 3% of the incremental increase in EBITDA over $12,000,000), provide for a profits-based additional bonus of up to $250,000 in certain limited circumstances, and provide for one (1) year severance, plus a pro-rated amount of any unpaid bonus earned by him during the year as verified by the Company’s principal financial officer, if Mr. Galvin is terminated without cause. At the Company’s option, up to fifty (50%) percent of the EBITDA performance bonuses may be paid in restricted stock units if then available for grant under the Company’s Incentive Plan.
CY2022Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	500000	usd

Files In Submission

Name	View Source	Status
0001213900-23-038569-index-headers.html	Edgar Link	pending
0001213900-23-038569-index.html	Edgar Link	pending
0001213900-23-038569.txt	Edgar Link	pending
0001213900-23-038569-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex312_2.htm	Edgar Link	pending
ex321_3.htm	Edgar Link	pending
ex322_4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20230331.htm	Edgar Link	pending
sgbx-20230331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sgbx-20230331_def.xml	Edgar Link	unprocessable
sgbx-20230331_cal.xml	Edgar Link	unprocessable
sgbx-20230331_lab.xml	Edgar Link	unprocessable
sgbx-20230331_pre.xml	Edgar Link	unprocessable
sgbx-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2023 Q2 Form 10-Q Financial Statement

#000121390023038569 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2023 Q2 Form 10-Q Financial Statement

#000121390023038569 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx